Fundraising Fox

Videobot

27 employees on LinkedIn · 3 known investors

Videobot is an agentic video engagement platform for the pharmaceutical industry, providing interactive video experiences that let healthcare professionals take actions such as downloading studies, accessing gated portals, or registering for webinars. It integrates with CRMs like Veeva and operates on SOC 2-certified, GDPR-compliant infrastructure to meet MLR and industry standards.

Also known as Videobot Oy

Investors · 3

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Company profile

researched Aug 2026

Videobot is a Finland-based SaaS company that builds an interactive video experience (iVX) platform, positioned as an agentic video engagement platform for the pharmaceutical industry. The product converts linear video into guided, user-led journeys: viewers are presented with choices and questions, and each choice can lead to another video, a web page, a form or another action. Journeys are modular, so individual videos and paths can be updated without rebuilding the whole experience. Customers can use existing approved videos, have content produced by the Videobot team, or generate new video modules with the platform's Agentic AI Creator.

Experiences can be placed across digital and physical touchpoints as an iFrame embed, an on-site widget, a Stories format, a slider, or via links and dynamically generated QR codes, allowing use on websites, portals, campaigns, rep follow-up emails, event materials and field tools. A dashboard consolidates measurement across placements, covering entry points, viewer choices, watch time and completion, drop-off points, CTA clicks and submitted forms, plus downstream actions such as portal visits, study downloads and webinar registrations when configured as CTAs. Interaction data can also be exported to GA4, GTM/Piwik PRO, Adobe Analytics, Matomo or custom integrations, and can be connected to CRM and field workflows including Veeva-based processes.

The company markets three audience-facing use cases: HCP engagement, consumer healthcare and OTC, and patient support and adherence. The platform is described as SOC 2 Type I and Type II certified, with data encrypted in transit and at rest, role-based access controls, anonymised analytics that avoid user-identifiable profiles, no traditional cookies or local storage for identification, and account and analytics data hosted in European data centres.

Founding story

The founders' thesis was that consumer attention has shifted to video — with the average consumer reported as spending around 17 hours a week with online video — and that interactive video is the next step after marketing automation in how brands guide customers through journeys. Co-founder Anssi Kiviranta framed video experience (VX) as the next phase in customer experience, arguing that interactive video content can guide users through personalised journeys rather than replacing text and images outright.

Business model

B2B SaaS: Videobot licenses its interactive video experience platform to brands and agencies, combined with a high-touch service model that includes expert consultants for iVX strategy, content production support, proactive optimisation advice and a managed content database. Client time investment is described as roughly 1–5 hours per month depending on the case.

Software platform sold to enterprise clients alongside content production and advisory services; specific pricing is not disclosed.

Traction

The website reports presence in 25+ countries, 25 years' worth of streamed video and 250,000+ monthly interactions. Earlier coverage cited customers in over 20 countries and stated that companies using Videobot can see up to 5x higher conversion rates. Published cases include Alfasigma Mexico (certified medical courses for healthcare professionals), LNDS (data services) and a partnership with Terve Media.

Latest developments

Videobot has repositioned its platform around pharmaceutical HCP, consumer healthcare and patient-support engagement, introduced an Agentic AI Creator for video module production, and announced a strategic partnership with Terve Media to launch interactive medical education for pharmaceutical companies in Finland. It also published a Consumer Study 2025 on interactive video in customer experience.

Full profile — market position, technology, go-to-market, geography, history

Market position

Positions itself as an interactive video experience (iVX) category player, framing VX as the successor to marketing automation platforms in customer engagement, with a specialisation in regulated pharmaceutical and healthcare communication.

Combination of branching interactive video with omnichannel placement formats and unified cross-placement analytics; a compliance posture aimed at regulated pharma use (SOC 2 Type I and II, GDPR-aligned handling, European hosting, Veeva integration); an agentic AI content creation capability; and a consultant-led, high-touch delivery model rather than self-serve software alone.

Technology

Interactive video journey engine with branching choices, connected paths, forms and calls to action; an Agentic AI Creator for producing new video modules; and, per earlier descriptions, automated script generation for new Videobots and suggestions for high-performing follow-up content based on analysis of existing performance. Delivery options include iFrame, widget, Stories, slider, links and dynamic QR codes. Analytics are built in and can be piped to GA4, GTM/Piwik PRO, Adobe Analytics, Matomo or custom endpoints. Security and privacy claims include SOC 2 Type I and II certification, encryption in transit and at rest, role-based permissions, European data hosting and anonymised analytics without cookie- or local-storage-based identification. Documentation covers content creation, building interactive Videobots, publishing and embedding, and analytics.

Go-to-market

Direct enterprise sales through named commercial contacts (CCO, enterprise account manager, director of strategic accounts) with "book a call" and contact-form conversion paths on the website, supported by published customer cases and a consultative, high-touch service model. Partnerships with media and industry players extend distribution, such as the strategic partnership with Finnish healthcare media company Terve Media.

Pharmaceutical companies and healthcare brands seeking to engage healthcare professionals, consumer healthcare and OTC marketers, and patient support programmes; more broadly, brands and agencies running customer-experience and marketing journeys. A partnership case targets pharmaceutical companies operating in Finland.

Geography

Headquartered in Turku, Finland (Yliopistonkatu 31, 20100 Turku) with a Luxembourg office (9 Rue du Laboratoire, 1911 Gare Luxembourg). The company reports usage in 25+ countries; earlier 2025 coverage cited customers in 20+ countries. Referenced deployments include Finland (Terve Media), Mexico (Alfasigma) and Luxembourg (LNDS).

History

Videobot was founded in 2022 by Anssi Kiviranta and Matias Mäenpää in Turku, Finland. It raised an initial €2.2 million in 2023 and a further €500k through Business Finland's Young Innovative Company programme, followed by a €2.8 million round announced in February 2025 led by Volta Ventures, Expon Capital and Superhero Capital, bringing total funding to €5.5 million. Originally described as an omnichannel interactive short-form video platform merging short video and chatbots for customer experience, the company now positions its iVX platform for the pharmaceutical industry and operates from Turku, Finland and Luxembourg.

Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Countries with Videobot usageJan 202525
Customer countriesFeb 202520
Monthly interactionsJan 2025250,000 interactions/month
Streamed videoJan 202525 years' worth of streamed video
Total funding raisedFeb 2025€5.5 million total funding

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 3

launches, deals, and filings
Feb 2025
Videobot raises €2.8 million led by Volta Ventures, Expon Capital and Superhero Capital

Turku-based Videobot closed a €2.8 million round to further develop its video experience (VX) platform, bringing total funding to €5.5 million. The round followed an initial €2.2 million raised in 2023 and €500k from Business Finland's Young Innovative Company programme.

source ↗

Jan 2025
Partnership with Terve Media for interactive medical education in Finland

Terve Media, a Finnish healthcare media company, and Videobot announced a strategic partnership to bring interactive digital training solutions to pharmaceutical companies operating in Finland.

source ↗

Jan 2023
€500k awarded under Business Finland's Young Innovative Company programme

Videobot received €500k as part of Business Finland's Young Innovative Company funding programme, in addition to an initial €2.2 million raised in 2023.

source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

In the news

Research sources · 8

primary sources listed

8 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Videobot do?
Finnish interactive video platform that turns brand and medical video into guided, measurable engagement journeys.
Who are Videobot's investors?
Videobot's investors include Superhero Capital, Volta Ventures, Expon Capital.